Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a88c7595e1a85217793564c19c08f4a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aab7197a78423f6c3d8022eda0cd875c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
filingDate |
2002-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49819c9a63b0f4d582cca8dc604d56b3 |
publicationDate |
2002-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-02069995-A2 |
titleOfInvention |
Use of trail and antiprogestins for treating cancer |
abstract |
The present invention provides methods and compositions for treating cancer, and even more preferably, prostate cancer. In one aspect, the present invention comprises a method for inducing cell death in cancer cells comprising treating at least a portion of the cancer cells with an effective amount of TRAIL and an effective amount of an antiprogestin sufficient to induce apoptosis in at least a portion of the treated cancer cells. In another aspect, the present invention comprises a composition for treating cancer by inducing cell death in cancer cells comprising a pharmaceutical composition comprising an effective amount of TRAIL and an effective amount of an antiprogestin sufficient to induce apoptosis in at least a portion of the cancer cells exposed to the composition. In an embodiment, the antiprogestin is Mifepristone. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2659884-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2659884-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1645875-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6998116-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7285533-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011020933-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006037660-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007043365-A1 |
priorityDate |
2001-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |